Reynoso Jamie L. Insider Trades & Stock Holdings

CEO, Medicare Advantage · Clover Health Investments, Corp. · Latest filing Oct 7, 2026

Reynoso Jamie L., CEO, Medicare Advantage at Clover Health Investments, Corp. has 3 Form 4 trades on file since Sep 17, 2026. Open-market activity: 0 purchases ($0) and 3 sales ($56.72K), net -$56.72K. Latest filing: disposed of 2.01K shares of $CLOV on Oct 7, 2026 at $4.63.

Trades on file

3

Open-market bought

$0

Open-market sold

$56.72K

Net open-market

-$56.72K

Latest filing

Oct 7, 2026

All insider trades by Reynoso Jamie L.

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 7, 2026	$CLOV	Sell (Open-market sale) 10b5-1	2.01K	$4.63	$9.29K			+5.0%			CEO, Medicare Advantage		—
Oct 5, 2026	$CLOV	Sell (Open-market sale) 10b5-1	8.75K	$4.42	$38.67K			+2.1%			CEO, Medicare Advantage		—
Sep 17, 2026	$CLOV	Sell (Open-market sale) 10b5-1	1.92K	$4.56	$8.76K			-0.7%			CEO, Medicare Advantage		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Reynoso Jamie L. traded

• $CLOV

Frequently asked questions

Has Reynoso Jamie L. been buying or selling stock?

Reynoso Jamie L. has 0 open-market purchases and 3 open-market sales on file, net -$56.72K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Reynoso Jamie L.'s latest insider trade?

disposed of 2.01K shares of $CLOV on Oct 7, 2026 at $4.63.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.